MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 72.0 ¤675,374 NL
RO.CH Roche Holding Ltd 60.6 ¤376,088 CH
HSBA.GB HSBC Holdings Plc 53.2 ¤355,433 GB
NOVN.CH Novartis AG 48.2 ¤293,014 CH
AZN.GB AstraZeneca PLC 63.6 ¤264,033 GB

Five Smallest Companies
Symbol Name Grade Market Cap Country
HAL.NL HAL Trust 63.6 ¤16,928 NL
BOL.SE Boliden AB 65.2 ¤17,263 SE
CARL.B.DK Carlsberg AS Class B 51.4 ¤18,139 DK
STMN.CH Straumann Holding AG 52.9 ¤18,205 CH
HLMA.GB Halma plc 58.7 ¤18,431 GB

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 72.0 34 NL
ACN Accenture Plc Class A 58.2 33 IE
DNB.NO DNB Bank ASA 56.1 30 NO
ALV.DE Allianz SE 51.6 29 DE
LR.FR Legrand SA 54.3 29 FR
NOVO.B.DK Novo Nordisk A/S Class B 67.0 29 DK
TEL TE Connectivity plc 68.8 27 IE
ETN Eaton Corp. Plc 56.9 26 IE
MUV2.DE Munchener Ruckversicherungs-Gesellschaft 53.1 26 DE
SAND.SE Sandvik AB 53.8 25 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤87,911
Median Market Cap ¤52,379
Avg. 3 Mo. Dollar Vol. ¤213,171,961
Avg. 3 Mo. Trading Vol. 3,815,465
Last Rebalance Date 03/23/2026
Companies Replaced 38
Biggest Sector Increase Industrials
Biggest Sector Decrease Health Care

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 18.5
Forward P/E Ratio (12 Mo.) 15.3
Price/Book Ratio 3.6
Avg. Revenue Chg. - 3 Yr 19.6%
Avg. Op. Income Chg. - 3 Yr. 46.0%
Avg. EPS Growth - 3 Yr. 13.7%
Avg. EPS Growth - 1 Yr. 14.1%
Avg. Operating Margin 19.6%
Avg. LT Debt to Total Capital 40.9%
Avg. Return on Equity 19.1%
Dividend Yield 2.1%
Index Average Grade
Europe 100 Index 56.68
Country Breakdown
United Kingdom 19.0%
Ireland 12.0%
Switzerland 11.0%
Germany 11.0%
Italy 8.0%
France 8.0%
Netherlands 8.0%
Sweden 8.0%
Spain 4.0%
Denmark 3.0%
Finland 2.0%
Luxembourg 2.0%
Austria 2.0%
Norway 1.0%
United States Of America 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE